107 related articles for article (PubMed ID: 38808735)
1. Quantifying chemotherapy-induced cognitive impairment in gastrointestinal cancer patients: A scoping review of methodological concerns in the literature.
Lau J; Khoo AM; Choe L; Hoon A; Tan KK
Asia Pac J Clin Oncol; 2024 May; ():. PubMed ID: 38808735
[TBL] [Abstract][Full Text] [Related]
2. Neuroimmune reactivity marker expression in rodent models of chemotherapy-induced cognitive impairment: A systematic scoping review.
George RP; Semendric I; Hutchinson MR; Whittaker AL
Brain Behav Immun; 2021 May; 94():392-409. PubMed ID: 33516919
[TBL] [Abstract][Full Text] [Related]
3. Either called "chemobrain" or "chemofog," the long-term chemotherapy-induced cognitive decline in cancer survivors is real.
Argyriou AA; Assimakopoulos K; Iconomou G; Giannakopoulou F; Kalofonos HP
J Pain Symptom Manage; 2011 Jan; 41(1):126-39. PubMed ID: 20832978
[TBL] [Abstract][Full Text] [Related]
4. The Role of Oxidative Stress in Etiopathogenesis of Chemotherapy Induced Cognitive Impairment (CICI)-"Chemobrain".
Gaman AM; Uzoni A; Popa-Wagner A; Andrei A; Petcu EB
Aging Dis; 2016 May; 7(3):307-17. PubMed ID: 27330845
[TBL] [Abstract][Full Text] [Related]
5. The 2013 SFRBM discovery award: selected discoveries from the butterfield laboratory of oxidative stress and its sequela in brain in cognitive disorders exemplified by Alzheimer disease and chemotherapy induced cognitive impairment.
Butterfield DA
Free Radic Biol Med; 2014 Sep; 74():157-74. PubMed ID: 24996204
[TBL] [Abstract][Full Text] [Related]
6. The effectiveness of anti-inflammatory agents in reducing chemotherapy-induced cognitive impairment in preclinical models - A systematic review.
Haller OJ; Semendric I; George RP; Collins-Praino LE; Whittaker AL
Neurosci Biobehav Rev; 2023 May; 148():105120. PubMed ID: 36906244
[TBL] [Abstract][Full Text] [Related]
7. An update on neurobiological mechanisms involved in the development of chemotherapy-induced cognitive impairment (CICI).
Murillo LC; Sutachan JJ; Albarracín SL
Toxicol Rep; 2023; 10():544-553. PubMed ID: 37396847
[TBL] [Abstract][Full Text] [Related]
8. Plausible biochemical mechanisms of chemotherapy-induced cognitive impairment ("chemobrain"), a condition that significantly impairs the quality of life of many cancer survivors.
Ren X; Boriero D; Chaiswing L; Bondada S; St Clair DK; Butterfield DA
Biochim Biophys Acta Mol Basis Dis; 2019 Jun; 1865(6):1088-1097. PubMed ID: 30759363
[TBL] [Abstract][Full Text] [Related]
9. Dysregulation of cytokine mediated chemotherapy induced cognitive impairment.
Ren X; St Clair DK; Butterfield DA
Pharmacol Res; 2017 Mar; 117():267-273. PubMed ID: 28063894
[TBL] [Abstract][Full Text] [Related]
10. Chemobrain: An accelerated aging process linking adenosine A
Oliveros A; Poleschuk M; Cole PD; Boison D; Jang MH
Int Rev Neurobiol; 2023; 170():267-305. PubMed ID: 37741694
[TBL] [Abstract][Full Text] [Related]
11. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
12. An Overview on Chemotherapy-induced Cognitive Impairment and Potential Role of Antidepressants.
Das A; Ranadive N; Kinra M; Nampoothiri M; Arora D; Mudgal J
Curr Neuropharmacol; 2020; 18(9):838-851. PubMed ID: 32091339
[TBL] [Abstract][Full Text] [Related]
13. Chemotherapy-Induced Cognitive Impairment.
Kinsley K; Pritchett W
Clin J Oncol Nurs; 2023 Mar; 27(2):205-208. PubMed ID: 37677835
[TBL] [Abstract][Full Text] [Related]
14. Animal models of chemotherapy-induced cognitive decline in preclinical drug development.
John J; Kinra M; Mudgal J; Viswanatha GL; Nandakumar K
Psychopharmacology (Berl); 2021 Nov; 238(11):3025-3053. PubMed ID: 34643772
[TBL] [Abstract][Full Text] [Related]
15. Functional changes of the prefrontal cortex, insula, caudate and associated cognitive impairment (chemobrain) in NSCLC patients receiving different chemotherapy regimen.
Liu S; Ni J; Yan F; Yin N; Li X; Ma R; Wu J; Zhou G; Feng J
Front Oncol; 2022; 12():1027515. PubMed ID: 36408140
[TBL] [Abstract][Full Text] [Related]
16. Serum neurofilament light chain levels as biomarker of paclitaxel-induced cognitive impairment in patients with breast cancer: a prospective study.
Argyriou AA; Karteri S; Bruna J; Mariotto S; Simo M; Velissaris D; Kalofonou F; Cavaletti G; Ferrari S; Kalofonos HP
Support Care Cancer; 2022 Feb; 30(2):1807-1814. PubMed ID: 34599664
[TBL] [Abstract][Full Text] [Related]
17. The selective cyclooxygenase-2 inhibitor NS398 ameliorates cisplatin-induced impairments in mitochondrial and cognitive function.
Rashid MA; Tang JJ; Yoo KH; Corujo-Ramirez A; Oliveros A; Kim SH; Ullah F; Altawell R; Hawse JR; Cole PD; Jang MH
Front Mol Neurosci; 2023; 16():1295991. PubMed ID: 38095013
[TBL] [Abstract][Full Text] [Related]
18. The microbiota-gut-brain axis: An emerging therapeutic target in chemotherapy-induced cognitive impairment.
Subramaniam CB; Bowen JM; Gladman MA; Lustberg MB; Mayo SJ; Wardill HR
Neurosci Biobehav Rev; 2020 Sep; 116():470-479. PubMed ID: 32681936
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
